In summary, in a followup of a nationally representative cohort of female patients with diabetes, insulin use (mainly human insulin) for 3 years or more may be associated with breast cancer mortality, with a fully adjusted hazard ratio (95% confidence interval) of 2.006 (1.102–3.653). Here, INS is linked to breast carcinoma.